Saturday, October 3, 2026

Dollar Index Drops 10.8% as Euro Surges 14% in Global Currency Rebalancing

The US Dollar Index fell 10.8% in the first half of 2025 as the Euro gained 14% and the British Pound rose 7%, marking a major currency rebalancing across global markets. The shift coincides with Federal Reserve chair Jerome Powell's impending departure, creating uncertainty around US monetary policy direction. Currency volatility is expected to persist as traders position for potential policy changes under new Fed leadership.

LM Salvado
LM Salvado

March 21, 2026

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
Dollar Index Drops 10.8% as Euro Surges 14% in Global Currency Rebalancing
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The US Dollar Index fell 10.8% in the first half of 2025 as major currencies rallied against the greenback in a global rebalancing.1 The Euro surged 14% during the period while the British Pound advanced 7%, reflecting shifting expectations for Federal Reserve policy as Jerome Powell prepares to step down.1

The currency moves signal a fundamental shift in how global markets view US monetary policy. Dollar weakness accelerated as Powell's tenure nears its end, with traders positioning for potential policy changes under new leadership.1 The Bank of Canada and other central banks maintained cautious stances as currency volatility increased across developed economies.1

The pound traded at $1.3086 in late November, down 0.5% on the day, with currency traders closely monitoring the $1.30 level as key technical support.13 against the euro, hitting its lowest level since April 2023.EUR/USD benefited most from the 14% euro appreciation, while GBP/USD's 7% gain reflects both dollar weakness and UK-specific factors including fiscal policy concerns.1

Simon Phillips, Managing Director at No1 Currency, noted the pound remains under pressure despite year-to-date gains.4 The pattern suggests global currencies are recalibrating against the dollar as markets digest Fed transition developments and central bank policy divergence across major economies.

Technical analysts note the dollar index has stabilized after its initial 10.8% drop, but recovery remains fragile.1 The forex market continues pricing in uncertainty around US monetary policy direction, keeping pressure on the dollar across major pairs while global traders monitor key technical levels for positioning opportunities.5rem 0;">Related Coverage

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· March 18, 2026
    Fed meeting live updates: Federal Reserve expected to hold rates steady, share outlook amid Iran oil shock
  3. [3]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  4. [4]News articleYahoo Finance· March 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq rise for second day in a row with Fed decision on deck

In this story · Knowledge Files

Categories

Tags

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com